Presidio Medical Stock / BioTech & PharmaFounded: 2017

Presidio Medical, founded in 2016, is a healthcare technology firm dedicated to revolutionizing pain management. The company's mission is to deliver effective, personalized treatments for chronic pain sufferers using cutting-edge medical technology. Presidio Medical's technology aims to offer precise pain treatment options and solutions, striving to improve patient outcomes and enhance quality of life. The company is headquartered in San Francisco, California.

Register for Details

For more details on financing and valuation for Presidio Medical, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Presidio Medical.

Register Today

Presidio Medical investors also invested in these private companies


Management Team

Michael Onuscheck
Chief Executive Officer & Chairman
Michael Ackermann Ph.D
Andrew Sullivan MD
Chief Medical Officer
Sue Lee
Senior Executive Assistant
Scott Salys
Chief Research & Development and Operations Officer

Board Members

Benjamin Tsai
Invus Opportunities
Imran Eba
Action Potential Venture Capital
Juan-Pablo Mas
Action Potential Venture Capital

Other companies like Presidio Medical in the BioTech & Pharma sector

Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation

News Highlights

Presidio Medical Closes $72M Series C Funding Round
Presidio Medical said it recently closed a $72 million Series C funding round. Deerfield Management and existing investors Invus Opportunities and Action Potential Venture Capital participated in the round, as did ShangBay Capital, Presidio said. David Neustaedter of Deerfield Management Company has joined Presidio's board of directors, the medical device company said.
Updated on: Oct 3, 2023


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.